Henry Stusnick

Analyst

Henry Stusnick is an Analyst with the Investment team at RA Capital Management. Henry’s primary responsibility is to work on both public and private investments and serves as a Board Director for Kinaset Therapeutics. He also currently serves as CBO and COO of Research Alliance Corporation III and Research Alliance Corporation IV. Previously, as an Associate at RA Capital, Henry covered genetic medicine, ophthalmology, asthma/​COPD, and multiple orphan disease landscapes. Prior to RA Capital, Henry was an Investment Banking Analyst at SVB Leerink. Henry holds a BA in Biology and Economics from Dartmouth College.